Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects

BACKGROUND: Metformin is a commonly used antidiabetic medication which has demonstrated promise as an anticancer agent alone and in combination with conventional treatment regimens. There is increasing evidence that metformin can also generate immunomodulatory effects in solid tumors and is currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeramachaneni, Ratna, Yu, Wangjie, Newton, Jared M, Kemnade, Jan O, Skinner, Heath D, Sikora, Andrew G, Sandulache, Vlad C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261884/
https://www.ncbi.nlm.nih.gov/pubmed/34230113
http://dx.doi.org/10.1136/jitc-2021-002773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261884/
https://www.ncbi.nlm.nih.gov/pubmed/34230113
http://dx.doi.org/10.1136/jitc-2021-002773

Ejemplares similares